Merck backs GNS Healthcare

GNS Healthcare, a precision medicine AI company, has extended its Series D funding round, bringing the amount raised to $28 million.

GNS Healthcare, a precision medicine AI company, has extended its Series D funding round, bringing the amount raised to $28 million. The latest investor was Merck Global Health Innovation Fund.

Source: Press Release